Change of bone mineral density and biochemical markers of bone turnover in patients on suppressive L-thyroxine therapy for differentiated thyroid carcinoma

被引:0
|
作者
Hong, S. [1 ]
Park, W. [1 ]
Kim, S. [1 ]
Nam, M. [1 ]
Kim, Y. [1 ]
机构
[1] Inha Univ, Inchon, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
T339
引用
收藏
页码:S315 / S315
页数:1
相关论文
共 50 条
  • [1] Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma
    Heijckmann, AC
    Huijberts, MSP
    Geusens, P
    de Vries, J
    Menheere, PPCA
    Wolffenbuttel, BHR
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (01) : 23 - 29
  • [2] Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma
    Chen, CH
    Chen, JF
    Yang, BY
    Liu, RT
    Tung, SC
    Chien, WY
    Lu, YC
    Kuo, MC
    Hsieh, CJ
    Wang, PW
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2004, 103 (06) : 442 - 447
  • [3] Study of Very Long Term (> 25 years) L-Thyroxine Suppressive Therapy in Postmenopausal Women With Differentiated Thyroid Cancer: Effect on Bone Mineral Density and Bone Turnover Markers
    Mingo Dominguez, Maria Luisa de
    Martinez Diaz-Guerra, Guillermo
    Allo Miguel, Gonzalo
    Aramendi, Mercedes
    Hawkins, Federico
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [4] Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma
    Gorres, G
    Kaim, A
    Otte, A
    Gotze, M
    MullerBrand, J
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (06): : 690 - 692
  • [5] Markers of bone turnover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy
    Toivonen, J
    Tahtela, R
    Laitinen, K
    Risteli, J
    Valimaki, MJ
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 138 (06) : 667 - 673
  • [6] Bone Mineral Density in Male Patients with L-Thyroxine Suppressive Therapy and Graves Disease
    E. Jódar
    G. Martínez-Díaz-Guerra
    S. Azriel
    F. Hawkins
    [J]. Calcified Tissue International, 2001, 69 : 84 - 87
  • [7] Bone mineral density in male patients with L-thyroxine suppressive therapy and Graves disease
    Jódar, E
    Martínez-Díaz-Guerra, G
    Azriel, S
    Hawkins, F
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2001, 69 (02) : 84 - 87
  • [8] Bone mineral density and bone turnover markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid cancer
    Lee, Mi Young
    Park, Jae Hyun
    Bae, Keum Seok
    Jee, Yong Gwan
    Ko, An Na
    Han, Yong Jea
    Shin, Jang Yel
    Lim, Jung Soo
    Chung, Choon Hee
    Kang, Seong Joon
    [J]. ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2014, 86 (02) : 55 - 60
  • [9] Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L-thyroxine suppressive therapy
    Mazokopakis, Elias E.
    Starakis, Ioannis K.
    Papadomanolaki, Maria G.
    Batistakis, Antony G.
    Papadakis, John A.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (07) : 1369 - 1373
  • [10] Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma
    Zanella, Andre Borsatto
    Marmitt, Laura
    Fighera, Tayane Muniz
    Scheffel, Rafael Selbach
    Spritzer, Poli Mara
    Dora, Jose Miguel
    Maia, Ana Luiza
    [J]. METABOLITES, 2022, 12 (09)